Results 251 to 260 of about 292,285 (303)
Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India. [PDF]
World J NephrolWani MA +7 more
europepmc +1 more source
The surgical implications of the posttransplant lymphoproliferative disorders. [PDF]
, 1991 Boillot, O +7 more
core
Rapidly progressive varicella zoster virus vasculopathy in a chemotherapy- and steroid-immunosuppressed patient with refractory diffuse large B-cell lymphoma: diagnostic and therapeutic challenges. [PDF]
Blood ResMin KI, Min GJ, Eom KS, Cho SG.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Surgical Clinics of North America, 1999
Although several new immunosuppressive medications have been developed in the past decade, many possible avenues are yet to be explored. Although the newer agents have not reflected any clear benefit in patient or graft survival over CsA or tacrolimus, they have been useful in reducing the incidence and severity of rejection, reducing the concomitant ...
A, Jain +4 more
openaire +3 more sources
Although several new immunosuppressive medications have been developed in the past decade, many possible avenues are yet to be explored. Although the newer agents have not reflected any clear benefit in patient or graft survival over CsA or tacrolimus, they have been useful in reducing the incidence and severity of rejection, reducing the concomitant ...
A, Jain +4 more
openaire +3 more sources
Immunosuppressive drug therapy
Current Opinion in Rheumatology, 1994Interstitial lung disease frequently complicates rheumatic disorders, especially polymyositis-dermatomyositis, rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease. In this article, we review the current data supporting the use of azathioprine, cyclophosphamide, chlorambucil, cyclosporine, and methotrexate in the management of ...
W J, McCune, D K, Vallance, J P, Lynch
openaire +2 more sources
Current Opinion in Immunology, 1992
Although Cyclosporin A has improved transplant outcome, its use has serious limitations due to its narrow therapeutic window. New approaches to broaden this window exploit alternative drug formulations, pharmacokinetic profiling and new immunosuppressive agents, such as Rapamycin and Brequinar, which act in a synergistic fashion.
openaire +2 more sources
Although Cyclosporin A has improved transplant outcome, its use has serious limitations due to its narrow therapeutic window. New approaches to broaden this window exploit alternative drug formulations, pharmacokinetic profiling and new immunosuppressive agents, such as Rapamycin and Brequinar, which act in a synergistic fashion.
openaire +2 more sources
Immunosuppressive drug therapy
Current Opinion in Rheumatology, 1996Intravenous cyclophosphamide therapy for autoimmune disease continues to be the subject of many clinical trials, which in general have strongly supported its use in lupus nephritis but have failed to demonstrate efficacy in severe vasculitis or severe Wegener's granulomatosis.
openaire +2 more sources
Immunosuppressive Therapy for Asthma
Allergy and Asthma Proceedings, 1995Over the last four or five years, there have been some serious attempts to look for alternatives to corticosteroids in the management of severe bronchial asthma. Rheumatologists and dermatologists long ago recognized the importance of replacing corticosteroids with other agents.
openaire +2 more sources